COVID-19: Normalleşme sürecinde alerji kliniği

References (14)

1. Lewis D. Is the coronavirus airborne? Experts can’t agree. Nature 2020;580(7802):175
2. Somsen GA, van Rijn C, Kooij S, Bem RA, Bonn D. Small droplet aerosols in poorly ventilated spaces and SARSCoV-2 transmission [published online ahead of print, 2020 May 27]. Lancet Respir Med 2020;8(7):658-659
3. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China [published correction appears in Lancet. 2020 Jan 30;:]. Lancet 2020;395(10223):497-506
4. Naziroğlu T, Sözen S, Özkan P, Şeker S, Aksu K. A case of COVID-19 pneumonia presenting with acute urticaria [published online ahead of print, 2020 May 13]. Dermatol Ther 2020;e13575. doi:10.1111/dth.13575
5. Halpin DMG, Faner R, Sibila O, Badia JR, Agusti A. Do chronic respiratory diseases or their treatment affect the risk of SARS-CoV-2 infection?. Lancet Respir Med 2020;8(5):436-438
6. Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. Vital surveillances: the epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19)—China, 2020. China CDC Weekly. http://weekly.chinacdc.cn/en/article/ doi/10.46234/ccdcw2020.032. Erişim tarihi: 17.05.2020
7. Zhang JJ, Dong X, Cao YY, et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China [published online ahead of print, 2020 Feb 19]. Allergy 2020;10.1111/all.14238
8. Li X, Xu S, Yu M, et al. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. J Allergy Clin Immunol 2020;146(1):110-118
9. Jackson DJ, Busse WW, Bacharier LB, et al. Association of respiratory allergy, asthma, and expression of the SARSCoV-2 receptor ACE2. J Allergy Clin Immunol 2020;146(1):203-206.e3
10. Asthma and Allergy Foundation of America- www.aafa.org (Erişim tarihi: 16.05.2020)
11. Halpin DMG, Singh D, Hadfield RM. Inhaled corticosteroids and COVID-19: a systematic review and clinical perspective. Eur Respir J. 2020;55(5):2001009. Published 2020 May 7. doi:10.1183/13993003.01009-2020
12. Russell CD, Millar JE, Baillie JK. Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury. Lancet 2020;395(10223):473-475
13. Yamaya M, Nishimura H, Deng X, et al. Inhibitory effects of glycopyrronium, formoterol, and budesonide on coronavirus HCoV-229E replication and cytokine production by primary cultures of human nasal and tracheal epithelial cells. Respir Investig 2020;58(3):155-168
14. Matsuyama S, Kawase M,